Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-04-01

Clinical Trial Update: Study of Phosphate Levels in Patients With Chronic Kidney Disease [Phase 2]

View source ↗

Summary

Phase 2 study conducted by Vifor Pharma evaluating phosphate levels in patients with chronic kidney disease; trial completed with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Vifor Pharma | Conditions: Chronic Kidney Disease | Phase 2 | Status: COMPLETED | Results posted: 2014-04-01